Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simone Lederer

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Frontiers in Pharmacology|December 19, 2019
Additive Dose Response Models: Defining SynergySimone Lederer, Tjeerd M H Dijkstra, Tom Heskes
Frontiers in Pharmacology|February 23, 2018
Additive Dose Response Models: Explicit Formulation and the Loewe Additivity Consistency ConditionSimone Lederer, Tjeerd M H Dijkstra, Tom Heskes
Plos One|May 2, 2020
Investigating the effect of dependence between conditions with Bayesian Linear Mixed Models for motif activity analysisSimone Lederer, Tom Heskes, Simon J van Heeringen, et al.
Journal of Personalized Medicine|December 29, 2022
External Validation of COVID-19 Risk Scores during Three Waves of Pandemic in a German Cohort-A Retrospective StudyLukas Häger, Philipp Wendland, Stephanie Biergans, et al.
Cell|July 17, 2020
Longitudinal Isolation of Potent Near-Germline SARS-CoV-2-Neutralizing Antibodies from COVID-19 PatientsChristoph Kreer, Matthias Zehner, Timm Weber, et al.
Cell|September 18, 2020
Longitudinal Isolation of Potent Near-Germline SARS-CoV-2-Neutralizing Antibodies from COVID-19 PatientsChristoph Kreer, Matthias Zehner, Timm Weber, et al.
Critical Care (London, England)|August 18, 2021
Machine learning identifies ICU outcome predictors in a multicenter COVID-19 cohortHarry Magunia, Simone Lederer, Raphael Verbuecheln, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Frontiers in Pharmacology|December 19, 2019
Additive Dose Response Models: Defining SynergySimone Lederer, Tjeerd M H Dijkstra, Tom Heskes
Frontiers in Pharmacology|February 23, 2018
Additive Dose Response Models: Explicit Formulation and the Loewe Additivity Consistency ConditionSimone Lederer, Tjeerd M H Dijkstra, Tom Heskes
Plos One|May 2, 2020
Investigating the effect of dependence between conditions with Bayesian Linear Mixed Models for motif activity analysisSimone Lederer, Tom Heskes, Simon J van Heeringen, et al.
Journal of Personalized Medicine|December 29, 2022
External Validation of COVID-19 Risk Scores during Three Waves of Pandemic in a German Cohort-A Retrospective StudyLukas Häger, Philipp Wendland, Stephanie Biergans, et al.
Cell|July 17, 2020
Longitudinal Isolation of Potent Near-Germline SARS-CoV-2-Neutralizing Antibodies from COVID-19 PatientsChristoph Kreer, Matthias Zehner, Timm Weber, et al.
Cell|September 18, 2020
Longitudinal Isolation of Potent Near-Germline SARS-CoV-2-Neutralizing Antibodies from COVID-19 PatientsChristoph Kreer, Matthias Zehner, Timm Weber, et al.
Critical Care (London, England)|August 18, 2021
Machine learning identifies ICU outcome predictors in a multicenter COVID-19 cohortHarry Magunia, Simone Lederer, Raphael Verbuecheln, et al.
Pageof 1